Zobrazeno 1 - 10
of 16
pro vyhledávání: '"E. D. Saad"'
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
OBJECTIVE: The 21-gene expression assay may support the decision regarding use of chemotherapy in early breast cancer. We sought to investigate the potential impact of incorporating the 21-gene expression assay into private practice in Brazil, from t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8df577a0c459ef67a2d430ac3e9d7466
https://doi.org/10.1590/s0104-42302010000200017
https://doi.org/10.1590/s0104-42302010000200017
Autor:
Cecília M. A. Pinheiro, William Rotea, Gustavo Borghesi, E. D. Saad, F. E. Prisco, Andrea M. Faingezicht, André L. S. Masson
Publikováno v:
Revista Brasileira de Cancerologia, Vol 55, Iss 3 (2009)
A pesquisa clínica está crescendo no Brasil, e muitos dos estudos recentes importantes no campo da oncologia incluíram um número substancial de pacientes brasileiros. Entretanto, é difícil estabelecer até que ponto ocorreu um aumento proporcio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdbe22a0afa0a0adb7e3f1044d0f58a0
https://rbc.inca.gov.br/revista/index.php/revista/article/view/1610
https://rbc.inca.gov.br/revista/index.php/revista/article/view/1610
Publikováno v:
Revista da Associacao Medica Brasileira (1992). 55(4)
OBJECTIVE: Breast cancer, a leading type of cancer in many developing countries, is the most frequent non-cutaneous tumor in Brazil. Hormone therapy is the standard of care in the adjuvant treatment of early-stage, hormone-receptor-positive disease,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a99ab1150b9c1cd49ccc607b8f6ea531
https://pubmed.ncbi.nlm.nih.gov/19750307
https://pubmed.ncbi.nlm.nih.gov/19750307
Publikováno v:
Oncology (Williston Park, N.Y.). 15(1 Suppl 2)
Researchers, primarily in Japan, Europe, and the United States, have evaluated several new fluorinated pyrimidines in recent years. Most of these drugs are orally active prodrugs of fluorouracil (5-FU), and some also contain modulators of its pharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f1d47989c140f6e0c7a0e4466619c04
https://pubmed.ncbi.nlm.nih.gov/11219980
https://pubmed.ncbi.nlm.nih.gov/11219980
Publikováno v:
Oncology (Williston Park, N.Y.). 14(10 Suppl 9)
The use of combined modality regimens has been well established in the treatment of stages II and III rectal cancer. The most common chemotherapy regimens used include continuous-infusion 5-FU delivered with the help of a central venous catheter and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::99ef821ec1fe31003c1e303b9b45aaa1
https://pubmed.ncbi.nlm.nih.gov/11098495
https://pubmed.ncbi.nlm.nih.gov/11098495
Autor:
E D, Saad, H, Grunspun
Publikováno v:
Revista do Hospital das Clinicas. 51(1)
Evidence-based medicine has been described as a new approach to teaching and practicing clinical medicine. Although the search for evidence is an established practice among physicians, what is being proposed is the systematic gathering and critical i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8d64a85f64891b9f64e063535d6b2380
https://pubmed.ncbi.nlm.nih.gov/8762653
https://pubmed.ncbi.nlm.nih.gov/8762653
Autor:
E. D. Saad, M. S. Militao
Publikováno v:
Journal of Clinical Oncology. 29:e13070-e13070
e13070 Background: The choice of the NI margin has become an important aspect of NI cancer trials, but the contemporary practice regarding this choice has not been formally assessed. Methods: We se...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::893b65e78835eda1d7f1220133bebe33
https://doi.org/10.1200/jco.2011.29.15_suppl.e13070
https://doi.org/10.1200/jco.2011.29.15_suppl.e13070
Autor:
E. D. Saad, G. N. Marta, L. G. Del Nero, A. Mangabeira, G. Critchi, J. L. F. da Silva, P. M. Hoff
Publikováno v:
Journal of Clinical Oncology. 29:e19524-e19524
e19524 Background: Relatively little is known about societal priorities regarding treatment goals in medical oncology, and the choice between prioritizing ST or QOL might depend on having been diag...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0004297390c35d7da54da3c480f02ae2
https://doi.org/10.1200/jco.2011.29.15_suppl.e19524
https://doi.org/10.1200/jco.2011.29.15_suppl.e19524
Publikováno v:
Journal of Clinical Oncology. 28:6116-6116
6116 Background: Full publication of RCTs presented as abstracts in scientific meetings may reduce publication bias, facilitate systematic reviews, and expedite implementation of therapeutic interv...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20b3de702c762856cccf53ef8082e2ab
https://doi.org/10.1200/jco.2010.28.15_suppl.6116
https://doi.org/10.1200/jco.2010.28.15_suppl.6116
Publikováno v:
Journal of Clinical Oncology. 27:e17525-e17525
e17525 Background: The pharmaceutical industry (PI) plays an important role in drug development. We examined the extent and correlates of declared PI involvement in abstracts presented at ASCO Meetings 2001–2003 and 2006–2008. Methods: After stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ecf1df8330bbc5a681d2db1b263ff8a
https://doi.org/10.1200/jco.2009.27.15_suppl.e17525
https://doi.org/10.1200/jco.2009.27.15_suppl.e17525